BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 37483794)

  • 21. Knockdown of PHF5A Inhibits Migration and Invasion of HCC Cells via Downregulating NF-
    Yang Q; Zhang J; Xu S; Jia C; Meng W; Tang H; Zhang X; Zhang Y; Fu B
    Biomed Res Int; 2019; 2019():1621854. PubMed ID: 30766880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression patterns of Phf5a/PHF5A and Gja1/GJA1 in rat and human endometrial cancer.
    Falck E; Klinga-Levan K
    Cancer Cell Int; 2013 May; 13(1):43. PubMed ID: 23675859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SIRT7-Induced PHF5A Decrotonylation Regulates Aging Progress Through Alternative Splicing-Mediated Downregulation of CDK2.
    Yu AQ; Wang J; Jiang ST; Yuan LQ; Ma HY; Hu YM; Han XM; Tan LM; Wang ZX
    Front Cell Dev Biol; 2021; 9():710479. PubMed ID: 34604215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plant homeodomain-finger protein 5A: A key player in cancer progression.
    Diaba-Nuhoho P
    Biomed Pharmacother; 2023 Dec; 169():115857. PubMed ID: 37951028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PHF5A facilitates the development and progression of gastric cancer through SKP2-mediated stabilization of FOS.
    Zhang Z; Peng L; Yang W; Li B; Hua Y; Luo S
    J Transl Med; 2023 Jan; 21(1):5. PubMed ID: 36609277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The SF3b Complex is an Integral Component of the Spliceosome and Targeted by Natural Product-Based Inhibitors.
    Larsen NA
    Subcell Biochem; 2021; 96():409-432. PubMed ID: 33252738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of a novel murine multigene family containing a PHD-finger-like motif.
    Trappe R; Ahmed M; Gläser B; Vogel C; Tascou S; Burfeind P; Engel W
    Biochem Biophys Res Commun; 2002 May; 293(2):816-26. PubMed ID: 12054543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.
    Selinger M; Věchtová P; Tykalová H; Ošlejšková P; Rumlová M; Štěrba J; Grubhoffer L
    Comput Struct Biotechnol J; 2022; 20():2759-2777. PubMed ID: 35685361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploiting Cryo-EM Structural Information and All-Atom Simulations To Decrypt the Molecular Mechanism of Splicing Modulators.
    Borišek J; Saltalamacchia A; Spinello A; Magistrato A
    J Chem Inf Model; 2020 May; 60(5):2510-2521. PubMed ID: 31539251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PHF5A is a potential diagnostic, prognostic, and immunological biomarker in pan-cancer.
    Ding N; Li M; Zhao X
    Sci Rep; 2023 Oct; 13(1):17521. PubMed ID: 37845358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The phosphorylation of PHF5A by TrkA-ERK1/2-ABL1 cascade regulates centrosome separation.
    Song C; Zhang Y; Li Y; Bie J; Wang Z; Yang X; Li H; Zhu L; Zhang T; Chang Q; Luo J
    Cell Death Dis; 2023 Feb; 14(2):98. PubMed ID: 36759599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A genome-wide siRNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment.
    Siebring-van Olst E; Blijlevens M; de Menezes RX; van der Meulen-Muileman IH; Smit EF; van Beusechem VW
    Mol Oncol; 2017 May; 11(5):534-551. PubMed ID: 28296343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between SAP155 and FUSE-binding protein-interacting repressor bridges c-Myc and P27Kip1 expression.
    Matsushita K; Tamura M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Levens D; He L; Liu J; Yoshida M; Nomura F
    Mol Cancer Res; 2013 Jul; 11(7):689-98. PubMed ID: 23594796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses.
    Schreiber CA; Sakuma T; Izumiya Y; Holditch SJ; Hickey RD; Bressin RK; Basu U; Koide K; Asokan A; Ikeda Y
    PLoS Pathog; 2015 Aug; 11(8):e1005082. PubMed ID: 26244496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.
    Sun G; Zhou H; Chen K; Zeng J; Zhang Y; Yan L; Yao W; Hu J; Wang T; Xing J; Xiao K; Wu L; Ye Z; Xu H
    J Exp Clin Cancer Res; 2020 Jun; 39(1):116. PubMed ID: 32560659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug.
    Alors-Perez E; Blázquez-Encinas R; Alcalá S; Viyuela-García C; Pedraza-Arevalo S; Herrero-Aguayo V; Jiménez-Vacas JM; Mafficini A; Sánchez-Frías ME; Cano MT; Abollo-Jiménez F; Marín-Sanz JA; Cabezas-Sainz P; Lawlor RT; Luchini C; Sánchez L; Sánchez-Hidalgo JM; Ventura S; Martin-Hijano L; Gahete MD; Scarpa A; Arjona-Sánchez Á; Ibáñez-Costa A; Sainz B; Luque RM; Castaño JP
    J Exp Clin Cancer Res; 2021 Dec; 40(1):382. PubMed ID: 34857016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Caenorhabditis elegans ortholog of human PHF5a shows a muscle-specific expression domain and is essential for C. elegans morphogenetic development.
    Trappe R; Schulze E; Rzymski T; Fröde S; Engel W
    Biochem Biophys Res Commun; 2002 Oct; 297(4):1049-57. PubMed ID: 12359262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
    Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
    Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms and Regulation of Alternative Pre-mRNA Splicing.
    Lee Y; Rio DC
    Annu Rev Biochem; 2015; 84():291-323. PubMed ID: 25784052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo.
    Martinez E; Palhan VB; Tjernberg A; Lymar ES; Gamper AM; Kundu TK; Chait BT; Roeder RG
    Mol Cell Biol; 2001 Oct; 21(20):6782-95. PubMed ID: 11564863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.